|
1
|
Kota SK and Kota SB: Noncoding RNA and
epigenetic gene regulation in renal diseases. Drug Discov Today.
22:1112–1122. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen L, Yang T, Lu D-W, Zhao H, Feng Y-L,
Chen H, Chen DQ, Vaziri ND and Zhao YY: Central role of
dysregulation of TGF-β/Smad in CKD progression and potential
targets of its treatment. Biomed Pharmacother. 101:670–681.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Webster AC, Nagler EV, Morton RL and
Masson P: Chronic Kidney Disease. Lancet. 389:1238–1252.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Regeniter A, Freidank H, Dickenmann M,
Boesken WH and Siede WH: Evaluation of proteinuria and GFR to
diagnose and classify kidney disease: Systematic review and proof
of concept. Eur J Intern Med. 20:556–561. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou L, Chen X, Lu M, Wu Q, Yuan Q, Hu C,
Miao J, Zhang Y, Li H, Hou FF, et al: Wnt/β-catenin links oxidative
stress to podocyte injury and proteinuria. Kidney Int. 95:830–845.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nagata M: Podocyte injury and its
consequences. Kidney Int. 89:1221–1230. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu M, Liang K, Zhen J, Zhou M, Wang X,
Wang Z, Wei X, Zhang Y, Sun Y, Zhou Z, et al: Sirt6 deficiency
exacerbates podocyte injury and proteinuria through targeting Notch
signaling. Nat Commun. 8(413)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Assady S, Wanner N, Skorecki KL and Huber
TB: New Insights into Podocyte Biology in Glomerular Health and
Disease. J Am Soc Nephrol. 28:1707–1715. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang T, Gao Y, Wang X, Shi Y, Xu J, Wu B,
He J and Li Y: Calpain-10 drives podocyte apoptosis and renal
injury in diabetic nephropathy. Diabetes Metab Syndr Obes.
12:1811–1820. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schiffer M, Bitzer M, Roberts IS, Kopp JB,
ten Dijke P, Mundel P and Böttinger EP: Apoptosis in podocytes
induced by TGF-β and Smad7. J Clin Invest. 108:807–816.
2001.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jaswani P, Prakash S, Dhar A, Sharma RK,
Prasad N and Agrawal S: MicroRNAs involvement in renal
pathophysiology: A bird's eye view. Indian J Nephrol. 27:337–341.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lorenzen JM, Kaucsar T, Schauerte C,
Schmitt R, Rong S, Hübner A, Scherf K, Fiedler J, Martino F,
Kumarswamy R, et al: MicroRNA-24 antagonism prevents renal ischemia
reperfusion injury. J Am Soc Nephrol. 25:2717–2729. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu Y, Bi X, Xiong J, Han W, Xiao T, Xu X,
Yang K, Liu C, Jiang W, He T, et al: MicroRNA-34a promotes renal
fibrosis by downregulation of Klotho in tubular epithelial cells.
Mol Ther. 27:1051–1065. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Long J, Wang Y, Wang W, Chang BH and
Danesh FR: MicroRNA-29c is a signature microRNA under high glucose
conditions that targets Sprouty homolog 1, and its in vivo
knockdown prevents progression of diabetic nephropathy. J Biol
Chem. 286:11837–11848. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pang Q, Wang Y, Bi D and Lu H: LRRC75A-AS1
targets miR-199b-5p/PDCD4 axis to repress multiple myeloma. Cancer
Biol Ther. 21:1051–1059. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lai Y, Quan J, Lin C, Li H, Hu J, Chen P,
Xu J, Guan X, Xu W, Lai Y, et al: miR-199b-5p serves as a tumor
suppressor in renal cell carcinoma. Exp Ther Med. 16:436–444.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Miao R, Lu Y, Xing X, Li Y, Huang Z, Zhong
H, Huang Y, Chen AF, Tang X, Li H, et al: Regulator of G-Protein
signaling 10 negatively regulates cardiac remodeling by blocking
mitogen-activated protein kinase–extracellular signal-regulated
protein kinase 1/2 signaling. Hypertension. 67:86–98.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Almutairi F, Lee J-K and Rada B: Regulator
of G protein signaling 10: Structure, expression and functions in
cellular physiology and diseases. Cell Signal.
75(109765)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li S, Liu Y, He X, Luo X, Shi H, Qu G, Wen
X, Gan W, Wang J and Zhang A: tRNA-Derived Fragments in Podocytes
with Adriamycin-Induced Injury Reveal the Potential Mechanism of
Idiopathic Nephrotic Syndrome. BioMed Res Int.
2020(7826763)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Peng B, Hu Q, Liu X, Wang L, Chang Q, Li
J, Tang J, Wang N and Wang Y: Duchesnea phenolic fraction
inhibits in vitro and in vivo growth of cervical cancer through
induction of apoptosis and cell cycle arrest. Exp Biol Med
(Maywood). 234:74–83. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu LJ, Duan Y, Wang P and Yin HQ:
miR-199b-5p promotes tumor growth and metastasis in cervical cancer
by down-regulating KLK10. Biochem Biophys Res Commun. 503:556–563.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ren L, Xu Y, Qin G, Liu C, Yan Y and Zhang
H: miR-199b-5p-Stonin 2 axis regulates metastases and
epithelial-to-mesenchymal transition of papillary thyroid
carcinoma. IUBMB Life. 71:28–40. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Wang H, Guo Y, Mi N and Zhou L: miR-101-3p
and miR-199b-5p promote cell apoptosis in oral cancer by targeting
BICC1. Mol Cell Probes. 52(101567)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kang WL and Xu GS: Atrasentan increased
the expression of klotho by mediating miR-199b-5p and prevented
renal tubular injury in diabetic nephropathy. Sci Rep.
6(19979)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Alqinyah M, Almutairi F, Wendimu MY and
Hooks SB: RGS10 regulates the expression of cyclooxygenase-2 and
tumor necrosis factor alpha through a G protein-independent
mechanism. Mol Pharmacol. 94:1103–1113. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cacan E, Ali MW, Boyd NH, Hooks SB and
Greer SF: Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression
and Decrease Ovarian Cancer Chemoresistance. PLoS One.
9(e87455)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang S, Chen W, Stashenko P and Li Y-P:
Specificity of RGS10A as a key component in the RANKL signaling
mechanism for osteoclast differentiation. J Cell Sci.
120:3362–3371. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xu J, Deng Y, Wang Y, Sun X, Chen S and Fu
G: SPAG5-AS1 inhibited autophagy and aggravated apoptosis of
podocytes via SPAG5/AKT/mTOR pathway. Cell Prolif.
53(e12738)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yingjie K, Haihong Y, Lingwei C, Sen Z,
Yuanting D, Shasha C, Liutong P, Ying W and Min Z: Apoptosis
repressor with caspase recruitment domain deficiency accelerates
ischemia/reperfusion (I/R)-induced acute kidney injury by
suppressing inflammation and apoptosis: The role of AKT/mTOR
signaling. Biomed Pharmacother. 112(108681)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cai J, Zhang Y, Huang S, Yan M, Li J, Jin
T and Bao S: miR-100-5p, miR-199a-3p and miR-199b-5p induce
autophagic death of endometrial carcinoma cell through targeting
mTOR. Int J Clin Exp Pathol. 10:9262–9272. 2017.PubMed/NCBI
|
|
34
|
Yang R, Yi L, Dong Z, Ouyang Q, Zhou J,
Pang Y, Wu Y, Xu L and Cui H: Tigecycline inhibits glioma growth by
regulating miRNA-199b-5p-HES1-AKT pathway. Mol Cancer Ther.
15:421–429. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Altman MK, Alshamrani AA, Jia W, Nguyen
HT, Fambrough JM, Tran SK, Patel MB, Hoseinzadeh P, Beedle AM and
Murph MM: Suppression of the GTPase-activating protein RGS10
increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Cancer Lett. 369:175–183. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shelley B: Hooks, Phillip Callihan, Molly
K Altman, Jillian H Hurst, Mourad W Ali, Mandi M Murph. Regulators
of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in
ovarian cancer cells. Mol Cancer. 9(289)2010.PubMed/NCBI View Article : Google Scholar
|
